Rendrevie Sun Screen SPF35 PA
Dosage form: cream
Ingredients: OCTINOXATE 5.625mL in 75mL, TITANIUM DIOXIDE 3.89mL in 75mL, OCTISALATE 2.25mL in 75mL
Labeler: Cellinbio Co Ltd
NDC Code: 76173-1001
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Active ingredient
Octinoxate 7.50%
Titanium Dioxide 5.19%
Octisalate 3.00%
Sunscreen
Keep out of reach of children
If swallowed, get medical help or contact a Posion Control Center right away.
Directions
Apply liberally 15 minutes before sun exposure
Use a water resistant sunscreen if swimming or sweating
Reapply at least every 2 hours
Children under 6 months: Ask a doctor
Warnings
Skin Cancer/Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to prevent sunburn, not skin cancer or early skin aging
For extenal use only
Do not use on damaged or broken skin
When using this product keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if rash occurs.
Helps prevent sunburn
Water, Cyclopentasiloxane, Glycerin, Dipropylene Glycol, Peg-10 Dimethicone, Hexyl Laurate, Talc, Dimethicone, Dimethicone/Vinyl Dimethicone Crosspolymer, Disteardimonium Hectorite, Magnesium Sulfate, Aluminum Hydroxide, Aluminum Stearate, Fragrance, Imidazolidinyl Urea, Methylparaben, Propylparaben, Aloe Barbadensis Leaf Juice, Chamomilla Recutita(Matricaria) Flower Extract, Lavandula Angustifolia(Lavender) Extract, Panax Ginseng Root Extract, Squalane, Iron Oxides(CI 77492, CI 77491, CI 77499), Butylparaben, Methicone
NRC Rendrevie sun sunscreen SPF35 PA++
Net WT. 2.54FL OZ(75ml)
| RENDREVIE SUN SCREEN SPF35 PA
octinoxate, titanium dioxide, octisalate cream |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Labeler - Cellinbio Co Ltd (557803737) |
| Registrant - Cellinbio Co Ltd (557803737) |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| Cellinbio Co Ltd | 557803737 | relabel | |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| KOLMAR KOREA CO LTD | 687846360 | manufacture | |
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
